SCP
VCYT icon

Syntal Capital Partners’s Veracyte VCYT Stock Holding History

Syntal Capital Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,372
Closed -$1.75M – 282
2019
Q2 		$1.75M Buy
+61,372
New +$1.53M 0.38% 62

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Syntal Capital Partners's VCYT Position: Q3 2019 in Review

Syntal Capital Partners sold out of Veracyte (VCYT) in Q3 2019, closing a stake of 61,372 shares — an estimated $1.75M sold.

Syntal Capital Partners first reported a position in VCYT in Q2 2019 and held it in 1 quarter. The position peaked at $1.75M in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Syntal Capital Partners reported no remaining Veracyte position as of Q3 2019 after selling out during the quarter.
  • Syntal Capital Partners sold 61,372 Veracyte shares in Q3 2019, an estimated $1.75M.
  • Syntal Capital Partners first reported a position in Veracyte in Q2 2019 and held it in 1 quarter.
  • Syntal Capital Partners's Veracyte position peaked at $1.75M in Q2 2019.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Syntal Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.